These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 14654753)
1. Circulating coupling factor 6 in human hypertension: role of reactive oxygen species. Osanai T; Sasaki S; Kamada T; Fujiwara N; Nakano T; Tomita H; Matsunaga T; Magota K; Okumura K J Hypertens; 2003 Dec; 21(12):2323-8. PubMed ID: 14654753 [TBL] [Abstract][Full Text] [Related]
2. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension : modulation of nitric oxide synthesis by salt intake. Fujiwara N; Osanai T; Kamada T; Katoh T; Takahashi K; Okumura K Circulation; 2000 Feb; 101(8):856-61. PubMed ID: 10694524 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. Dishy V; Sofowora GG; Imamura H; Nishimi Y; Xie HG; Wood AJ; Stein CM J Hypertens; 2003 Jan; 21(1):153-7. PubMed ID: 12544447 [TBL] [Abstract][Full Text] [Related]
5. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension]. Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662 [TBL] [Abstract][Full Text] [Related]
6. Relation of sodium-potassium adenosine triphosphatase inhibitor to sympathetic nervous system during salt-loading in essential hypertension. Shima H; Nishio I; Tsuda K; Yoshikawa H; Kimura K; Hano T; Masuyama Y Jpn J Med; 1989; 28(2):165-9. PubMed ID: 2525203 [TBL] [Abstract][Full Text] [Related]
7. Changes in the plasma hANP level during long-term salt loading in patient with essential hypertension. Ogihara T; Hara H; Shima J; Iinuma K; Kumahara Y Clin Exp Hypertens A; 1988; 10(1):105-17. PubMed ID: 2964952 [TBL] [Abstract][Full Text] [Related]
8. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Li XL; Xing QC; Dong B; Gao YY; Xing SS; Pang YZ; Jiang HF; Tang CS Int J Cardiol; 2007 May; 117(3):411-2. PubMed ID: 16899312 [TBL] [Abstract][Full Text] [Related]
9. Effect of sodium restriction on platelet function in patients with essential hypertension. Ikeda T; Gomi T; Sakurai J; Toya Y; Fujinami K; Yuhara M; Ikegami F Jpn Heart J; 1989 May; 30(3):365-73. PubMed ID: 2529381 [TBL] [Abstract][Full Text] [Related]
10. Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension. Bragulat E; de la Sierra A; Antonio MT; Jiménez W; Urbano-Márquez A ; Coca A Clin Sci (Lond); 2001 Jul; 101(1):73-8. PubMed ID: 11410117 [TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Osanai T; Nakamura M; Sasaki S; Tomita H; Saitoh M; Osawa H; Yamabe H; Murakami S; Magota K; Okumura K Kidney Int; 2003 Dec; 64(6):2291-7. PubMed ID: 14633154 [TBL] [Abstract][Full Text] [Related]
12. Nutritional regulation of coupling factor 6, a novel vasoactive and proatherogenic peptide. Osanai T; Mikami K; Kitajima M; Urushizaka M; Kawasaki K; Tomisawa T; Itaki C; Noto Y; Magota K; Tomita H Nutrition; 2017 May; 37():74-78. PubMed ID: 28359367 [TBL] [Abstract][Full Text] [Related]
13. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Fang Y; Mu JJ; He LC; Wang SC; Liu ZQ Hypertension; 2006 Oct; 48(4):724-9. PubMed ID: 16966580 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of coupling factor 6 causes cardiac dysfunction under high-salt diet in mice. Ashitate T; Osanai T; Tanaka M; Magota K; Echizen T; Izumiyama K; Yokoyama H; Shibutani S; Hanada K; Tomita H; Okumura K J Hypertens; 2010 Nov; 28(11):2243-51. PubMed ID: 20811295 [TBL] [Abstract][Full Text] [Related]